552 related articles for article (PubMed ID: 10799914)
21. HLA-A*0201-restricted T cells from humanized NOD mice recognize autoantigens of potential clinical relevance to type 1 diabetes.
Takaki T; Marron MP; Mathews CE; Guttmann ST; Bottino R; Trucco M; DiLorenzo TP; Serreze DV
J Immunol; 2006 Mar; 176(5):3257-65. PubMed ID: 16493087
[TBL] [Abstract][Full Text] [Related]
22. Mature mainstream TCR alpha beta+CD4+ thymocytes expressing L-selectin mediate "active tolerance" in the nonobese diabetic mouse.
Herbelin A; Gombert JM; Lepault F; Bach JF; Chatenoud L
J Immunol; 1998 Sep; 161(5):2620-8. PubMed ID: 9725264
[TBL] [Abstract][Full Text] [Related]
23. Pancreatic IL-4 expression results in islet-reactive Th2 cells that inhibit diabetogenic lymphocytes in the nonobese diabetic mouse.
Gallichan WS; Balasa B; Davies JD; Sarvetnick N
J Immunol; 1999 Aug; 163(3):1696-703. PubMed ID: 10415077
[TBL] [Abstract][Full Text] [Related]
24. Self-specific MHC class II-restricted CD4-CD8- T cells that escape deletion and lack regulatory activity.
Viret C; Janeway CA
J Immunol; 2003 Jan; 170(1):201-9. PubMed ID: 12496401
[TBL] [Abstract][Full Text] [Related]
25. I-Ag7-mediated antigen presentation by B lymphocytes is critical in overcoming a checkpoint in T cell tolerance to islet beta cells of nonobese diabetic mice.
Noorchashm H; Lieu YK; Noorchashm N; Rostami SY; Greeley SA; Schlachterman A; Song HK; Noto LE; Jevnikar AM; Barker CF; Naji A
J Immunol; 1999 Jul; 163(2):743-50. PubMed ID: 10395666
[TBL] [Abstract][Full Text] [Related]
26. Major histocompatibility complex class II molecules can protect from diabetes by positively selecting T cells with additional specificities.
Lühder F; Katz J; Benoist C; Mathis D
J Exp Med; 1998 Feb; 187(3):379-87. PubMed ID: 9449718
[TBL] [Abstract][Full Text] [Related]
27. MHC-mismatched mixed chimerism mediates thymic deletion of cross-reactive autoreactive T cells and prevents insulitis in nonobese diabetic mice.
Racine JJ; Zhang M; Wang M; Morales W; Shen C; Zeng D
J Immunol; 2015 Jan; 194(1):407-17. PubMed ID: 25429069
[TBL] [Abstract][Full Text] [Related]
28. alpha/beta-T cell receptor (TCR)+CD4-CD8- (NKT) thymocytes prevent insulin-dependent diabetes mellitus in nonobese diabetic (NOD)/Lt mice by the influence of interleukin (IL)-4 and/or IL-10.
Hammond KJ; Poulton LD; Palmisano LJ; Silveira PA; Godfrey DI; Baxter AG
J Exp Med; 1998 Apr; 187(7):1047-56. PubMed ID: 9529321
[TBL] [Abstract][Full Text] [Related]
29. Early autoimmune destruction of islet grafts is associated with a restricted repertoire of IGRP-specific CD8+ T cells in diabetic nonobese diabetic mice.
Wong CP; Li L; Frelinger JA; Tisch R
J Immunol; 2006 Feb; 176(3):1637-44. PubMed ID: 16424193
[TBL] [Abstract][Full Text] [Related]
30. Thymic development of autoreactive T cells in NOD mice is regulated in an age-dependent manner.
He Q; Morillon YM; Spidale NA; Kroger CJ; Liu B; Sartor RB; Wang B; Tisch R
J Immunol; 2013 Dec; 191(12):5858-66. PubMed ID: 24198282
[TBL] [Abstract][Full Text] [Related]
31. Two mechanisms for the non-MHC-linked resistance to spontaneous autoimmunity.
Verdaguer J; Amrani A; Anderson B; Schmidt D; Santamaria P
J Immunol; 1999 Apr; 162(8):4614-26. PubMed ID: 10202001
[TBL] [Abstract][Full Text] [Related]
32. CD1d-specific NK1.1+ T cells with a transgenic variant TCR.
Sköld M; Faizunnessa NN; Wang CR; Cardell S
J Immunol; 2000 Jul; 165(1):168-74. PubMed ID: 10861049
[TBL] [Abstract][Full Text] [Related]
33. A role for accessibility to self-peptide-self-MHC complexes in intrathymic negative selection.
Viret C; Sant'Angelo DB; He X; Ramaswamy H; Janeway CA
J Immunol; 2001 Apr; 166(7):4429-37. PubMed ID: 11254698
[TBL] [Abstract][Full Text] [Related]
34. Autoreactive diabetogenic T-cells in NOD mice can efficiently expand from a greatly reduced precursor pool.
Serreze DV; Johnson EA; Chapman HD; Graser RT; Marron MP; DiLorenzo TP; Silveira P; Yoshimura Y; Nathenson SG; Joyce S
Diabetes; 2001 Sep; 50(9):1992-2000. PubMed ID: 11522664
[TBL] [Abstract][Full Text] [Related]
35. Suppressor of cytokine signaling-1 overexpression protects pancreatic beta cells from CD8+ T cell-mediated autoimmune destruction.
Chong MM; Chen Y; Darwiche R; Dudek NL; Irawaty W; Santamaria P; Allison J; Kay TW; Thomas HE
J Immunol; 2004 May; 172(9):5714-21. PubMed ID: 15100317
[TBL] [Abstract][Full Text] [Related]
36. Prevalent CD8(+) T cell response against one peptide/MHC complex in autoimmune diabetes.
Anderson B; Park BJ; Verdaguer J; Amrani A; Santamaria P
Proc Natl Acad Sci U S A; 1999 Aug; 96(16):9311-6. PubMed ID: 10430939
[TBL] [Abstract][Full Text] [Related]
37. MHC-mismatched islet allografts are vulnerable to autoimmune recognition in vivo.
Kupfer TM; Crawford ML; Pham K; Gill RG
J Immunol; 2005 Aug; 175(4):2309-16. PubMed ID: 16081800
[TBL] [Abstract][Full Text] [Related]
38. Absolute requirement of macrophages for the development and activation of beta-cell cytotoxic CD8+ T-cells in T-cell receptor transgenic NOD mice.
Jun HS; Santamaria P; Lim HW; Zhang ML; Yoon JW
Diabetes; 1999 Jan; 48(1):34-42. PubMed ID: 9892220
[TBL] [Abstract][Full Text] [Related]
39. CD8+ T lymphocytes in double alpha beta TCR transgenic mice. II. Competitive fitness of dual alpha beta TCR CD8+ T lymphocytes in the peripheral pools.
Legrand N; Freitas AA
J Immunol; 2001 Dec; 167(11):6158-64. PubMed ID: 11714775
[TBL] [Abstract][Full Text] [Related]
40. Human CD4 expression at the late single-positive stage of thymic development supports T cell maturation and peripheral export in CD4-deficient mice.
Boyer O; Marodon G; Cohen JL; Lejeune L; Irinopoulou T; Liblau R; Bruneval P; Klatzmann D
J Immunol; 2002 Oct; 169(8):4347-53. PubMed ID: 12370367
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
